Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 4
Submit an article Journal homepage
262
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Deep and partial immunoparesis is a poor prognostic factor for newly diagnosed multiple myeloma patients

Chuanying GengDepartment of Hematology, Beijing Chaoyang Hospital, Capital medical University, Beijing, ChinaView further author information
,
Guangzhong YangDepartment of Hematology, Beijing Chaoyang Hospital, Capital medical University, Beijing, ChinaView further author information
,
Huijuan WangDepartment of Hematology, Beijing Chaoyang Hospital, Capital medical University, Beijing, ChinaView further author information
,
Yin WuDepartment of Hematology, Beijing Chaoyang Hospital, Capital medical University, Beijing, ChinaView further author information
,
Yun LengDepartment of Hematology, Beijing Chaoyang Hospital, Capital medical University, Beijing, ChinaView further author information
,
Huixing ZhouDepartment of Hematology, Beijing Chaoyang Hospital, Capital medical University, Beijing, ChinaView further author information
,
Zhiyao ZhangDepartment of Hematology, Beijing Chaoyang Hospital, Capital medical University, Beijing, ChinaORCID Iconhttps://orcid.org/0000-0002-6974-373XView further author information
ORCID Icon,
Yuan JianDepartment of Hematology, Beijing Chaoyang Hospital, Capital medical University, Beijing, ChinaView further author information
&
Wenming ChenDepartment of Hematology, Beijing Chaoyang Hospital, Capital medical University, Beijing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 883-890 | Received 14 Aug 2020, Accepted 19 Nov 2020, Published online: 04 Dec 2020

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019; 69:7–34.
  • Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011; 364:1046–1060.
  • Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–e548.
  • Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003; 78:21–33.
  • González-Calle V, Cerdá S, Labrador J, et al. Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma. Haematologica. 2017; 102:922–931.
  • Jimenez-Zepeda VH, Duggan P, Neri P, et al. Immunoparesis and polyclonal immunoglobulin recovery after auto-SCT for patients with multiple myeloma treated at a single institution. Leuk Lymphoma. 2018; 59:1920–1926.
  • Kastritis E, Zagouri F, Symeonidis A, et al.; for the Greek Myeloma Study Group. Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma. Leukemia. 2014;28:2075–2079.
  • Heaney JLJ, Campbell JP, Iqbal G, et al. Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials. Leukemia. 2018; 32:1727–1738.
  • Gao W, Li J, Jian Y, et al. Immunoparesis in symptomatic multiple myeloma at diagnosis affects PFS with bortezomib-containing induction therapy, but not ASCT consolidation. Int J Hematol. 2019;109:169–174.
  • Chakraborty R, Rybicki L, Nakashima MO, et al. Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma. Br J Haematol. 2020;189:1074–1082.
  • Gao W, Li J, Wu Y, et al. Immunoparesis recovery 1 year after ASCT is independently associated with favorable survival in patients with symptomatic multiple myeloma who undergo autologous stem cell transplantation. Ann Hematol. 2019;98:1177–1184.
  • Sarı M, Sarı S, Nalçacı M. The effect of suppressed levels of uninvolved immunoglobulins on the prognosis of symptomatic multiple myeloma. TJH. 2017; 34:131–136.
  • Merz M, Moehler TM, Ritsch J, et al. Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study. Eur Radiol. 2016; 26:1404–1411.
  • Sørrig R, Klausen TW, Salomo M, et al.; for the Danish Myeloma Study Group. Immunoparesis in newly diagnosed Multiple Myeloma patients: effects on overall survival and progression free survival in the Danish population. PLoS One. 2017;12:e0188988–15.
  • Durie BG, Harousseau JL, Miguel JS, et al.; International Myeloma Working Group. International uniform response criteria for multiple myeloma. Leukemia. 2006;20:1467–1473.
  • Ludwig H, Milosavljevic D, Berlanga O, et al. Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma. Am J Hematol. 2016; 91:295–301.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.